152 related articles for article (PubMed ID: 35850983)
1. Achilles Tendon Thickening as a Risk Factor of Cardiovascular Events after Percutaneous Coronary Intervention.
Matsumoto I; Kurozumi M; Namba T; Takagi Y
J Atheroscler Thromb; 2023 May; 30(5):491-501. PubMed ID: 35850983
[TBL] [Abstract][Full Text] [Related]
2. Achilles tendon thickening is associated with higher incidence of adverse cardiovascular event in patients with coronary artery disease.
Hashimoto T; Minami Y; Asakura K; Katamine M; Kato A; Katsura A; Sato T; Muramatsu Y; Kakizaki R; Fujiyoshi K; Ishida K; Kameda R; Meguro K; Shimohama T; Ako J
Heart Vessels; 2021 Feb; 36(2):163-169. PubMed ID: 32761364
[TBL] [Abstract][Full Text] [Related]
3. Impact of nonfasting triglycerides/high-density lipoprotein cholesterol ratio on secondary prevention in patients treated with statins.
Matsumoto I; Misaki A; Kurozumi M; Nanba T; Takagi Y
J Cardiol; 2018 Jan; 71(1):10-15. PubMed ID: 28916255
[TBL] [Abstract][Full Text] [Related]
4. Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention.
Kitahara H; Nakayama T; Fujimoto Y; Kobayashi Y
J Cardiol; 2020 Jun; 75(6):654-658. PubMed ID: 31992496
[TBL] [Abstract][Full Text] [Related]
5. Achilles tendon thickening is associated with disease severity and plaque vulnerability in patients with coronary artery disease.
Hashimoto T; Minami Y; Kakizaki R; Nemoto T; Fujiyoshi K; Meguro K; Shimohama T; Tojo T; Ako J
J Clin Lipidol; 2019; 13(1):194-200. PubMed ID: 30472278
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
[TBL] [Abstract][Full Text] [Related]
7. Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia.
Wang B; Zhang Q; Lin L; Pan LL; He CY; Wan XX; Zheng ZA; Huang ZX; Zou CB; Fu MC; Kutryk MJ
Lipids Health Dis; 2018 Jun; 17(1):131. PubMed ID: 29859112
[TBL] [Abstract][Full Text] [Related]
8. Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome.
Hao Y; Yang Y; Wang Y; Li J
Curr Med Res Opin; 2022 Oct; 38(10):1663-1672. PubMed ID: 35575139
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention.
Kitahara H; Mori N; Saito Y; Nakayama T; Fujimoto Y; Kobayashi Y
Heart Vessels; 2019 Oct; 34(10):1595-1599. PubMed ID: 30968218
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study.
Ogura M; Harada-Shiba M; Masuda D; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S; Yamashita S
J Atheroscler Thromb; 2022 Jun; 29(6):906-922. PubMed ID: 34108342
[TBL] [Abstract][Full Text] [Related]
11. The burden of major adverse cardiac events in patients with coronary artery disease.
Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
[TBL] [Abstract][Full Text] [Related]
12. Achilles tendon thickness is associated with coronary lesion severity in acute coronary syndrome patients without familial hypercholesterolemia.
Fujiwara R; Yahiro R; Horio T; Miyauchi M; Yoshimura R; Matsuoka Y; Yokouchi G; Sakamoto Y; Matsumoto N; Fukuda K; Izumiya Y; Yoshiyama M; Fujimoto K; Kasayuki N
J Cardiol; 2022 Feb; 79(2):311-317. PubMed ID: 34657775
[TBL] [Abstract][Full Text] [Related]
13. Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: from the FU-Registry.
Nagata I; Ike A; Nishikawa H; Zhang B; Sugihara M; Mori K; Iwata A; Kawamura A; Shirai K; Uehara Y; Ogawa M; Miura S; Saku K
J Cardiol; 2015 Feb; 65(2):105-11. PubMed ID: 24997801
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
[TBL] [Abstract][Full Text] [Related]
15. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of Achilles tendon thickness in elderly patients after percutaneous coronary intervention: A 5-year follow-up.
Isawa T; Horie K; Toyoda S; Taguri M
J Cardiol; 2023 Dec; 82(6):448-454. PubMed ID: 37506821
[TBL] [Abstract][Full Text] [Related]
17. Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention.
Matsumoto I; Miyake Y; Mizukawa M; Takagi Y
Circ J; 2011; 75(4):905-10. PubMed ID: 21325724
[TBL] [Abstract][Full Text] [Related]
18. Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment.
Wada H; Ogita M; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Suwa S; Daida H
Heart Vessels; 2017 Jan; 32(1):16-21. PubMed ID: 27107767
[TBL] [Abstract][Full Text] [Related]
19. Effect of Cerebrovascular and/or Peripheral Artery Disease With or Without Attainment of Lipid Goals on Long-Term Outcomes in Patients With Coronary Artery Disease.
Volis I; Saliba W; Jaffe R; Eitan A; Zafrir B
Am J Cardiol; 2020 Aug; 128():28-34. PubMed ID: 32650921
[TBL] [Abstract][Full Text] [Related]
20. Genetic mutations, regression of Achilles tendon thickness, and cardiovascular events among patients with familial hypercholesterolemia.
Tada H; Okada H; Nohara A; Takamura M; Kawashiri MA
Atherosclerosis; 2022 Jan; 340():28-34. PubMed ID: 34871818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
